- Published at
- by themarketherald.com.au
positive
positive
Island enrols first subjects for Phase 2b clinical trial for dengue fever drug
Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test ISLA-101 as progress rolls on.